Insider Transactions Reported by 18 Insiders of Alaunos Therapeutics, Inc.

Symbol
TCRT on Nasdaq
Location
Fort Lauderdale, FL

Insiders trading volume in the past year

Alaunos Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Robert W. Postma Director $335,666 +$5,454 +1.7% 12 Jan 2026
Jaime W. Vieser Director $145,755 +$1,123 +0.78% 12 Jan 2026
Kevin S. Boyle Sr. Chief Executive Officer, Director $111,993 01 Sep 2023
Raffaele Baffa Chief Medical Officer $39,374 17 May 2021
Ferdinand Groenewald Vice President of Finance $30,924 18 Aug 2025
Jerman A. Michael Director $27,712 12 Jan 2026
Heidi Hagen Director $20,468 02 Sep 2021
Christopher Bowden Director $6,197 22 Jun 2022
Drew Deniger Vice President, Research and Development 15 Mar 2023
Abhishek K. Srivastava Vice President, Technical Operations 15 Mar 2023
Melinda Lackey Legal & Administration 29 Mar 2025
Eleanor de Groot EVP, Operations 30 Mar 2022
Robert Hofmeister Director 06 Jun 2024
Dale Curtis Hogue Jr. Chief Executive Officer, Interim, Director 29 Mar 2025
Mary Thistle Director 06 Jun 2023
Holger Weis Chief Executive Officer, Director 18 Aug 2025
James Huang Director 06 Jun 2023
Michael Wong Vice President, Finance 15 Mar 2023

Recent Insider Transactions by Companies or Individuals for Alaunos Therapeutics, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Jerman A. Michael TCRT Common Stock Award 129.2% 5,406 9,589 12 Jan 2026 Direct
Robert W. Postma TCRT Common Stock Award 14.7% 5,622 43,872 12 Jan 2026 Direct
Jaime Vieser TCRT Common Stock Award 22% 5,839 32,338 12 Jan 2026 Direct
Jaime Vieser TCRT Common Stock Award 25.2% 5,340 26,499 21 Nov 2025 Direct
Robert W. Postma TCRT Common Stock Award 15.5% 5,142 38,250 21 Nov 2025 Direct
Jerman A. Michael TCRT Common Stock Award 4,183 4,183 21 Nov 2025 Direct
Ferdinand Groenewald TCRT Common Stock Award 10,775 10,775 18 Aug 2025 Direct
Ferdinand Groenewald TCRT Employee Stock Option (right to buy) Award 4,000 4,000 18 Aug 2025 Direct
Holger Weis TCRT Employee Stock Option (right to buy) Award 13,676 13,676 18 Aug 2025 Direct
Michael Allen Jerman TCRT Employee Stock Option (right to buy) Award 13,200 10,000 15 Jul 2025 Direct
Robert W. Postma TCRT Common Stock Award 13.9% 4,050 33,133 03 Jul 2025 Direct
Robert W. Postma TCRT Employee Stock Option (right to buy) Award 6,400 6,400 03 Jul 2025 Direct
Jaime Vieser TCRT Common Stock Award 19.2% 3,400 21,159 03 Jul 2025 Direct
Jaime Vieser TCRT Employee Stock Option (right to buy) Award 6,400 6,400 03 Jul 2025 Direct
Holger Weis TCRT Employee Stock Option (right to buy) Award 130,000 130,000 02 Jul 2025 Direct
Jaime Vieser TCRT Series A-2 Convertible Preferred Stock Purchase 250 250 24 Jun 2025 Direct
Robert W. Postma TCRT Series A-2 Convertible Preferred Stock Purchase 600 600 24 Jun 2025 By Watermill Asset Management Corp
Robert W. Postma TCRT Common Stock Award 251.3% 20,804 29,083 13 Apr 2025 Direct
Robert W. Postma TCRT Common Stock Award 251.3% 20,804 29,083 13 Apr 2025 Direct
Holger Weis TCRT Employee Stock Option (right to buy) Award 10,904 10,904 13 Apr 2025 Direct
Jaime Vieser TCRT Common Stock Award 67.4% 17,465 43,359 13 Apr 2025 Direct
Robert W. Postma TCRT Series A-1 Convertible Preferred Stock Purchase 500 500 11 Apr 2025 By WaterMill Asset Management Corp.
Robert W. Postma TCRT Series A-1 Convertible Preferred Stock Purchase 500 500 11 Apr 2025 By WaterMill Asset Management Corp.
Dale Curtis Hogue Jr. TCRT Employee Stock Option (right to buy) Award 3,000 3,000 29 Mar 2025 Direct
Melinda Lackey TCRT Employee Stock Option (right to buy) Award 1,000 1,000 29 Mar 2025 Direct
Ferdinand Groenewald TCRT Employee Stock Option (right to buy) Award 3,000 3,000 29 Mar 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.